Tuesday, September 1st, 2015 - NewsMaker

World's Largest Lung Cancer Research Organization to Offer Access to New Research, Public Policy Guidance at 16th World Conference on Lung Cancer

DENVER, CO - (Marketwired, Sep 1, 2015) - The International Association for the Study of Lung Cancer (IASLC) will host the 16th World Conference on Lung Cancer (WCLC) Sept. 6-9, 2015 in Denver, Colo. The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 6,000 researchers, physicians and specialists from more than 100 countries.

The four-day conference will cover a wide range of disciplines including more than 300 invited talks and 3,000 formal research studies and clinical trial results shared in oral, mini oral and poster sessions. The conference goal is to increase awareness and collaboration to ensure that surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied health professionals, advocates, caregivers and patients understand the latest developments and can implement them throughout the world.

Findings from the conference come from researchers across the globe. Media partners can attend the press conferences in person at the WCLC or remotely:

AGENDA:

Date: Sunday, September 6, 2015
Time: 11:30 - 12:30 MDT
Location: Colorado Convention Center, Room 108 + 110 + 112
Remote Access: https://attendee.gotowebinar.com/register/2723160817353458433(To access audio through telephone, click here for available numbers by country)

  • Introduction to WCLC, preview of Opening Ceremonies & Daily Theme - Dr. Fred R. Hirsch, IASLC CEO, Congress President, Professor of Medicine and Pathology, University of Colorado
  • Summary of the IASLC Third CT Screening Workshop - Dr. John Field, Chair, Screening advisory Committee, IASLC and Personal Clinical Chair in Molecular Oncology, University of Liverpool
  • Summary of Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session - Dr. ChunXue Bai, Session Chair and Director, Shanghai Respiratory Research Institute and Professor and Chair of the Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University
  • Advocacy and Patient Advocates - Janet Freeman-Daily, Lung Cancer Patient & Advocate
  • Q & A

Date: Monday, September 7, 2015
Time: 09:45 - 10:45 MDT
Location: Colorado Convention Center, Room 108 + 110 + 112
Remote Access: https://attendee.gotowebinar.com/register/2723160817353458433(To access audio through telephone, click here for available numbers by country)

  • Daily Theme: Lung Cancer Prevention & Screening - Dr. Claudia Henschke, Professor of Radiology and head of Lung and Cardiac Screening Program at Mount Sinai Medical Center, New York
  • New Tobacco Declaration from IASLC - Dr. Kenneth Michael Cummings, Professor, Hollings Cancer Center, Medical University of South Carolina and Co-Chair of IASLC's Tobacco Control and Smoking Cessation Committee
  • Abstract - Impact of Time to Drug Approval on Potential Years of Life Lost: The Compelling Need for Improved Trial and Regulatory Efficiency - Dr. David Stewart, Head, Division of Medical Oncology, University of Ottawa/The Ottawa Hospital
  • Abstract - Results From Phase III Trials of Anamorelin in Advanced Non-Small Cell Lung Cancer Patients with Cachexia: ROMANA 1 and 2 - Dr. Philip Bonomi, Professor, Rush University Medical Center - Medical Oncology, Chicago, Ill.
  • Abstract - Bevacizumab 15mg/kg Plus Cisplatin-Pemetrexed (CP) vs CP in Malignant Pleural Mesothelioma (MPM): IFCT-GFPC-0701 MAPS Randomized Phase 3 Trial - Dr. Arnaud Scherpereel, Head of the Pulmonary and Thoracic Oncology Department and Professor at the University Hospital (CHU) of Lille, France
  • Q & A

Date: Tuesday, September 8, 2015
Time: 09:45 - 10:45 MDT
Location: Colorado Convention Center, Room 108 + 110 + 112
Remote Access: https://attendee.gotowebinar.com/register/2723160817353458433(To access audio through telephone, click here for available numbers by country)

  • Daily Theme: Lung Cancer: A Women's Disease - Dr. Silvia Novello, Associate Professor, Department of Oncology, University of Turin-Italy
  • Revised (8th) Edition of TNM Staging System for Lung Cancer - Dr. Ramon Rami-Porta, Thoracic Surgery Service, Hospital Universitari Mutua Terrassa, Barcelona
  • 2015 WHO Classification of the Pathology and Genetics of Tumors of the Lung - Dr. William Travis, Attending Thoracic Pathologist, Dept. of Pathology, Memorial Sloan Kettering Cancer Center, New York
  • Abstract - Increasing Incidence of Non-Smoking Lung Cancer: Presentation of Patients with Early Disease to a Tertiary Institution in the UK - Dr. Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital Senior Lecturer, and Reader in Thoracic Surgery, National Heart and Lung Institute, Imperial College Abstract - Increasing Incidence of Never Smokers in Non Small Cell Lung Cancer (NSCLC) Patients - Dr. Lorraine Pelosof, Assistant Professor, UT Southwestern Medical Center, Dallas, Texas
  • Abstract - Oncogenic Profiling in Lung Adenocarcinoma Emerged in the Youth - Dr. Kosuke Tanaka, Department of Cancer Genetics, Nagoya University Graduate School of Medicine; Division of Molecular Oncology, Aichi Cancer Center Research Institute, Japan
  • Abstract - The Genomics of Young Lung Cancer Study - Dr. Barbara Gitlitz, Associate Professor of Clinical Medicine at USC Keck School of Medicine, LA
  • Q & A

Date: Wednesday, September 9, 2015
Time: 09:45 - 10:45 MDT
Location: Colorado Convention Center, Room 108 + 110 + 112
Remote Access: https://attendee.gotowebinar.com/register/2723160817353458433(To access audio through telephone, click here for available numbers by country)

  • Daily Theme: Science Drives Lung Cancer Advances - Dr. David R. Gandara, Professor of Medicine, Division of Hematology/Oncology, Director, Thoracic Oncology Program, Senior Advisor to the Director, UC Davis Comprehensive Cancer Center, Sacramento, California
  • Abstract - Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505 - Dr. Heather Wakelee, Associate Professor of Medicine (Oncology) at the Stanford University Medical Center, Stanford, California
  • Abstract - Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography (LDCT) Screening Volunteers - Dr. Ugo Pastorino, Director Thoracic Surgery, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy
  • Abstract - Multiregion Whole Exome and Transcriptome Sequencing Defines the Genomic Spectrum of EGFR+ NSCLC and Reveals Novel Mechanisms of TKI Resistance - Dr. Daniel Shao Weng Tan, Consultant, Medical Oncology, National Cancer Centre, Singapore
  • Abstract - A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): SWOG S0819 - Dr. Roy Herbst, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Director, Thoracic Oncology Research Program, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine
  • Abstract - EGFR IHC and FISH Correlative Analyses (SQUIRE Trial): Necitumumab + Gemcitabine-Cisplatin vs Gemcitabine-Cisplatin in 1st-Line Squamous NSCLC -Dr. Fred R. Hirsch, IASLC CEO, Congress President, Professor of Medicine and Pathology, University of Colorado
  • Q & A

REMOTE ATENDANCE: Members of the media who cannot attend the WCLC in person can participate in the press conference remotely here: https://attendee.gotowebinar.com/register/2723160817353458433(To access audio through telephone, click here for available numbers by country)

ABOUT THE WCLC: http://wclc2015.iaslc.org/. General and Media registration is now open.

ABOUT THE IASLC: https://www.iaslc.org/.

Contact:
Jeff Wolf
IASLC Director of Communications
[email protected]
720-325-2952

Chris Martin
Public Relations Manager
[email protected]
630-670-2745

Becky Bunn
IASLC Projects Specialist
[email protected]
720-325-2946

 

Contact Profile

NewsMaker


NewsMaker is an Australian Press Release Distribution and Social Media Marketing service founded in 2004. The company today represents over 22,000 brands who seek to share their content with journalists, bloggers and the community.


Newsmaker Editors
P: +61 414 69 70 71
W: www.newsmaker.com.au

Keywords

MEDIA ALERT: Press Conferences Remote Access

Categories

Sharing

More Formats